For decades, a diagnosis of pancreatic cancer felt like a death sentence. Doctors would deliver the news, and most patients — and their families — had little reason to feel hopeful. Today only about 13% of people who have pancreatic cancer are still alive five years later. If you compare that to other kinds of cancer you will see that the number of people who survive has gone up a lot because we have better treatments and we can find cancer sooner. Pancreatic cancer has not been getting better like other cancers have.. Now things might be getting better for people, with pancreatic cancer.

In May 2026 the doctors and the scientists have a lot to be happy about. They have found a drug called daraxonrasib that is really working. They also have a vaccine that is made just for this disease.. They have a device that uses electric fields to fight the disease. All of these things are giving people hope. For people like Vicky Stinson, who’s a 65 year old lady from Flagstaff, Arizona and used to design landscapes these new discoveries are very important. The disease is very bad. Now Vicky Stinson and other patients like her have something to be hopeful, about. The new drug daraxonrasib and the built vaccine are really making a difference.

Why Is Pancreatic Cancer So Hard to Fight?

To understand why these new treatments for cancer matter so much you first have to understand why pancreatic cancer is so difficult to deal with.Pancreatic cancer is difficult to deal with because the pancreas is an organ that is tucked behind many other organs in your abdomen.The pancreas is hard to find because of where it sits so it is nearly impossible to feel or see the pancreas during a checkup.When a patient notices something is wrong with their body, like some stomach pain or difficulty eating or they get sudden-onset diabetes the pancreatic cancer has usually already spread to other parts of the body.This is a problem because roughly 80 percent of patients are diagnosed with pancreatic cancer at a late stage when the pancreatic cancer is much harder to treat.

Even when doctors detect the cancer, treating it is a nightmare. These tumors build what one doctor describes as a “cocoon” around themselves — a thick protective layer that stops chemotherapy drugs from getting through. On top of that, the pancreas sits right next to the body’s major blood vessels. As oncologist Dr. Arif Kamal of the American Cancer Society explains, those vessels are like highways for the body. If cancer cells escape from the pancreas, they can travel quickly to other parts of the body. And unlike many other cancers that form solid, contained masses, pancreatic cancer cells tend to scatter easily — like a handful of sand, not a tennis ball. You simply cannot catch every grain.

The Pill That Is Changing Everything: Daraxonrasib

Now, a drug called daraxonrasib, developed by a company called Revolution Medicines, is turning heads across the medical world.The drug works by targeting a specific gene mutation found in most pancreatic cancers. This mutation, known as KRAS, acts like a broken traffic light stuck on green — it keeps sending signals for cancer cells to divide and grow without stopping. Daraxonrasib essentially locks that broken signal off, causing the cancer cells to slow down or stop growing altogether.

In a large Phase 3 clinical trial called RASolute 302, patients who took daraxonrasib — just one pill a day — lived an average of 13.2 months. Patients who received standard chemotherapy lived only 6.7 months on average. That means the new drug roughly doubled how long patients survived. In a disease where every extra month matters enormously to families, that is a stunning result.

This is really exciting because of the way patients took the medication. The thing about chemotherapy is that it usually means spending a lot of time at a hospital or clinic where you are connected to a drip with a tube, for hours.Daraxonrasib is a simple once-a-day pill taken at home. Patients in the trial reported far fewer brutal side effects than those on chemotherapy, and none of them dropped out of the trial because of side effects.

Vicky Stinson was one of the people who took this drug as part of an earlier clinical trial. She described her 13 months on daraxonrasib as “a full year of normalcy.” She hiked the Dolomite mountains in Italy. She kept up with her exercise classes. Her biggest complaint? A bit of acne on her face and neck — which, she joked, “brought her back to her teens.”

Because the results look really good the U.S. Food and Drug Administration has already let the drug be given to patients even before it gets full approval.Doctors and cancer experts are trying to figure out how to get it to patients.

A Vaccine Built Just for You

Daraxonrasib is not the only exciting development. Scientists are working on a kind of vaccine. This vaccine does not prevent diseases. Instead the cancer vaccine fights cancer that’s already in the body. The cancer vaccine uses mRNA technology. This is the technology used in some COVID-19 vaccines. Doctors at Memorial Sloan Kettering Cancer Center are using this technology. They are making built vaccines for people with pancreatic cancer.Here is how the cancer vaccine works. Doctors first look at the makeup of the tumor in each patient. Then they design a vaccine based on the profile of the patients tumor. They make a vaccine for each patient, with cancer. The cancer vaccine is made for that patient.

In a small trial of 16 patients, the vaccine activated a strong immune response in half of them. For those patients, the results were remarkable — many of them lived six years longer than expected. The researchers said the immune response is very strong and it seems to last for a time.Think of it like this: you are teaching your bodys defense system, which’s your immune system to know the exact “fingerprint” of your cancer and then attack it by itself.This way of doing things is still being tried out with people but the results so far are really surprising and people are taking notice of the immune system and how it can help with cancer and the immune system.

Fighting Cancer With Electricity

There is also a brand-new device that the FDA recently approved for treating pancreatic cancer. Electrodes are attached to the patient’s skin over the abdomen, and the device sends high-frequency electrical signals directly to the cancer cells. These signals disrupt the cancer cells as they try to divide and multiply, helping to kill them. As a bonus, the electrical signals appear to also trigger the body’s immune system to join the fight — without adding the harsh chemicals that chemotherapy introduces into the body.

Doctors who have started using the device are hopeful it could give patients two to three more months of life, and with less pain than traditional options. While it is not a cure, every extra month is time spent with family, time to try the next new treatment, time for science to catch up.

If I Can Just Hold On a Little Longer

Vicky Stinson’s cancer eventually came back after her 13 months on daraxonrasib. It spread to her ovaries and is now at Stage 4. She has returned to chemotherapy, which has been harder on her body. But she has not given up. She is now helping researchers study her cancer’s genetic profile, hoping scientists can design something new specifically for her case.

Her story reflects the experience of thousands of pancreatic cancer patients who are racing against the clock — and for the first time in a long time, science seems to be racing with them.

Researchers believe that daraxonrasib will become the backbone of future treatments. Combined with vaccines, immune therapies, and devices like the electric-field machine, the goal is not just to slow the cancer down — but eventually, to cure it.For a disease that once offered almost no hope, 2026 feels like the beginning of something real.

Picture this You walk into your doctor’s office, describe your symptoms, and while you’re sitting on that crinkly paper bed, your doctor pulls out their phone and quietly types something into an app. You assume they’re checking your chart. They’re not. They’re asking an AI.

This is happening in clinics and hospitals all across America right now. The tool is called OpenEvidence, and according to a recent NBC News investigation, about 65% of doctors in the United States are using it. That’s roughly 650,000 physicians. In April of this year alone, it showed up in nearly 27 million patient visits. Most patients never knew.

So What Is This Thing?

OpenEvidence is not your typical AI chatbot. It was built specifically for doctors and other healthcare professionals. Instead of pulling information from random corners of the internet, it searches through massive collections of real medical research — peer-reviewed studies, clinical guidelines, journal articles — and gives doctors a clear, organized answer fast.

Doctors sign up with their official government-issued healthcare ID number. When the students are inside they can ask the teacher many questions as they want about the lesson. The students can ask the teacher lots of questions. They can ask the teacher questions, about the lesson until they understand it.

The platform is based in Miami and was founded by a tech entrepreneur named Daniel Nadler. It’s backed by some heavy hitters in the investment world — Sequoia Capital, Google Ventures, Andreessen Horowitz, Nvidia, and Thrive Capital. A year ago, the company was worth around $1 billion. As of January 2026, that number had jumped to $12 billion. That kind of growth tells you how fast doctors have picked this up.

Why Are Doctors Reaching for It?

Doctors have always needed fast answers. For years, most of them used a service called UpToDate — long, detailed summaries of the latest research on just about every condition imaginable. It was reliable, but it wasn’t exactly quick. You had to know exactly what to search for, and even then, sifting through a lengthy article to find the one paragraph that actually answered your question took longer than most busy doctors had.

OpenEvidence works differently. A doctor can type a question the way they’d actually ask it out loud — something like, “my patient’s potassium just dropped and they’re on this medication, what do I do?” — and get a direct, relevant answer in seconds.

One doctor in New Hampshire used it when a patient’s potassium levels suddenly crashed. He needed to know fast whether it was a medication side effect or something more serious. OpenEvidence gave him a clear answer with treatment options right there on the spot.

A doctor working at a rural clinic in South Dakota was staring at an X-ray that might have shown a spinal fracture — or might not.He of recalled from medical school that some bone breaks do not appear clearly on X-rays so he asked OpenEvidence. It told him a CT scan would give a much more reliable answer and linked him to the studies that said so.

Dr. Paul Sax, an infectious disease specialist at Boston’s Brigham and Women’s Hospital, said that with older tools, hunting for specific answers was slow and clunky. With OpenEvidence, he described it as completely frictionless. You type what you actually want to know, and it finds it.

How Does It Stay Free?

Good question. The platform makes money through advertising. And here’s where things get a little uncomfortable — some of those ads come from pharmaceutical and medical device companies.

Most doctors who were interviewed said the ads are small, easy to ignore, and don’t get in the way of using the tool. But the fact remains: a platform that doctors use to make medical decisions is partly paid for by drug companies. That’s something worth knowing.

OpenEvidence also has licensing deals with some of the most respected medical journals on the planet, including the New England Journal of Medicine and JAMA, the Journal of the American Medical Association. That means when the tool generates an answer, it’s pulling from full research articles — not just abstracts or summaries — from the best sources in medicine.

Does It Get Things Right?

A lot of the time, yes. OpenEvidence reportedly scored a perfect 100% on the U.S. Medical Licensing Examination — the same test every doctor in the country has to pass. That’s a genuinely impressive result.

But here’s the thing. That exam covers standard medical knowledge. Real clinical practice is messier. A study published in December 2025 found that for more complicated, unusual medical questions — the kind that come up with rare diseases or tricky patient histories — OpenEvidence gave the correct answer less than 45% of the time. That study hasn’t been fully peer-reviewed yet, but it was enough to make a lot of researchers pay attention.

Experienced doctors say the tool handles everyday cases well. Where it stumbles is on the edge cases — the rare stuff that doesn’t come up often and where the research base is thin.

An emergency doctor in New York noticed it once overstated the liver risks of a certain medication in a patient whose real problem was heavy drinking. He came back weeks later and found the answer had been updated to be more accurate. But that kind of error, caught only because the doctor already knew enough to question it, is exactly what worries some people in the medical community.

What Are the Real Concerns Here?

The first is what this tool might do to younger doctors and medical students. Some physicians have noticed that newer doctors aren’t always building the same instincts that come from working through difficult cases on their own. When a tool does part of that thinking for you from the very start of your career, those muscles may never fully develop. One mid-career doctor in Missouri said it plainly — when you hand off part of a skill to a tool, you lose that part of the skill. 

The second concern is that nobody has done a serious, large-scale study on how OpenEvidence is actually affecting patient outcomes. The tool developed quickly. Doctors and researchers are, on it now. They are still working to get results. The tool is moving ahead of what they can study. Doctors and researchers are trying hard to catch up.

Then there’s the privacy question. OpenEvidence says it follows HIPAA, the federal health privacy law. But not every hospital is convinced. Some have told their doctors not to enter any patient-specific information into the platform at all.

What Should You Take Away From This?

Your doctor using a tool like OpenEvidence isn’t necessarily a bad thing. Doctors have always looked things up. Medical knowledge moves fast, and no one can keep every study and guideline stored in their head.

But you have every right to know about it. If your doctor is consulting an AI tool during your appointment, that’s something you can ask about. A good doctor won’t have a problem explaining it.

The bigger picture is that AI is already inside the exam room, whether we’re talking about it or not. That conversation is worth having out loud.

Hantavirus is back in the news, and this time it hits closer to home for Illinois residents. State health officials confirmed Tuesday that they are looking into a possible hantavirus infection in someone living in Winnebago County. Before the rumors start flying — no, this has nothing to do with the cruise ship story you may have already heard about. This is a totally separate situation, and officials say the risk to the general public is low. Here is everything worth knowing.

The Person Got Sick Cleaning Their Own Home

The Winnebago County resident did not travel to another country. They did not cross paths with anyone from the MV Hondius cruise ship. What they did was clean a home that had rodent droppings in it — and that appears to be where things went wrong.

Mice and rats carry hantavirus in their waste. When old, dried droppings get disturbed — swept up, vacuumed, or even just moved around — tiny particles can rise into the air. Breathe those particles in, and the virus enters your body. It happens fast and quietly, and most people do not even realize the danger until they start feeling sick.

Sandra Martell, the public health administrator for the Winnebago County Health Department, said it plainly: the resident had direct contact with rodent droppings while cleaning and developed symptoms that matched hantavirus exposure.

This Is Not the Cruise Ship Outbreak

Something big happened on the MV Hondius cruise ship over the few weeks. There was a hantavirus outbreak on the MV Hondius cruise ship. It got a lot of attention from people all around the country. The hantavirus outbreak, on the MV Hondius cruise ship was big news.Cases connected to that ship wound up at a facility in Nebraska and a hospital in Atlanta. It was serious — and alarming — because the strain involved, called the Andes strain, can actually spread from one person to another. That is unusual for hantavirus and part of why that situation raised so many red flags.

The Illinois case is believed to involve the North American strain. This version of the virus behaves very differently. It does not pass between people. You can be in the same room as someone who has it and not be at any risk of getting it yourself. The only way to get the North American strain is through direct contact with infected rodent waste — not through another human being.

Illinois health officials were direct about this: the Winnebago County resident had no international travel on record and no known connection to the cruise ship or anyone on it.

What Hantavirus Actually Does to the Body

Hantavirus is not something to brush off. In serious cases, it causes a condition called Hantavirus Pulmonary Syndrome, or HPS, where the lungs begin filling with fluid. Early on, it looks a lot like the flu — fever, body aches, tiredness, sometimes dizziness. But it can turn severe quickly, and when it does, breathing becomes very difficult. Without proper medical care, HPS can be fatal.

Dr. Alfredo Mena Lora, an infectious disease specialist at Saint Anthony Hospital, explained how the exposure usually happens: when someone cleans a space where rodents have been living, the dried waste can become airborne. Those particles carry the virus straight into the lungs. It is the kind of risk most people would never think twice about — cleaning out a garage, a basement, or an old shed — which is exactly why knowing about it matters.

How Uncommon Is This in Illinois?

Very uncommon. Before this current potential case, Illinois had confirmed just seven hantavirus infections going all the way back to 1993. The most recent one before this was in March 2025.

Nationally, the CDC recorded 890 total hantavirus cases across the United States between 1993 and 2023. Spread that out over 30 years and across the entire country, and the numbers are genuinely small. Illinois health officials stated clearly: the risk of catching hantavirus of any kind remains very low for people living in the state.

The Test Results Are Still Pending

There is one important detail here — this case has not been fully confirmed yet. The initial test used was a commercial antibody test, which the CDC does not consider a definitive result on its own. The CDC runs more thorough follow-up testing, but that process takes up to 10 days.

What You Should Actually Do If You Find Rodent Droppings

If you find rodent droppings in your home, here is the right way to handle it. First, open the windows and let the space air out for at least 30 minutes before you touch anything. Put on rubber gloves and wear an N95 mask if you have one. Spray the droppings with a disinfectant or a bleach and water mix, let it sit for a few minutes, and then wipe everything up with a damp cloth or paper towels. Bag it all up and throw it out. Never sweep or vacuum dry droppings — that is exactly how the particles become airborne and dangerous.

After you are done, wash your hands thoroughly and clean anything else that may have been exposed.

If your home has signs of an ongoing rodent problem, it is worth calling a pest control professional rather than handling it alone. Mice and rats are not just a nuisance — as this case in Winnebago County shows, they can be a genuine health risk.

Where Things Stand

Illinois public health officials are taking this seriously while also being honest that there is no widespread threat to communities right now. The IDPH said it will update the public if anything changes significantly.

For most Illinois residents, life goes on as normal. But for anyone cleaning out an old space at home this spring — take an extra minute to do it safely. That small step could make a real difference.